Medicinal product name Risonate 35 mg film-coated tablets
Pharmaceutical form Film-coated tablet
Strength 35 mg 
Information from the MAH on shortages Not available
predicted availability date: May 1, 2024
Legal status Rx Prescription (Pr.)
KZSR Reimbursed medicines reference product
Package leafletMS Word document 12-08-2021
Summary of product characteristicsMS Word document 19-11-2020
ATC code M05BA07 Drugs for treatment of bone diseases

Medicinal products (14)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(35 mg)
PVC/PVDC/Al blister    08-0339-01 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N2
(35 mg)
PVC/PVDC/Al blister    08-0339-02 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers)
predicted availability date: May 1, 2024
currently no information on availability from any wholesaler N4
(35 mg)
PVC/PVDC/Al blister 3.96 
KZSR*
08-0339-03 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N8
(35 mg)
PVC/PVDC/Al blister    08-0339-04 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N10
(35 mg)
PVC/PVDC/Al blister    08-0339-05 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers)
predicted availability date: May 1, 2024
currently no information on availability from any wholesaler N12
(35 mg)
PVC/PVDC/Al blister 11.89 
KZSR*
08-0339-06 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N14
(35 mg)
PVC/PVDC/Al blister    08-0339-07 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N16
(35 mg)
PVC/PVDC/Al blister    08-0339-08 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(35 mg)
PVC/PVDC/Al blister    08-0339-09 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N12: 3 × 4
(35 mg)
PVC/PVDC/Al blister    08-0339-10 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N16: 4 × 4
(35 mg)
PVC/PVDC/Al blister    08-0339-11 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N4: 4 × 1
(35 mg)
PVC/PVDC/Al blister    08-0339-12 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N10: 10 × 1
(35 mg)
PVC/PVDC/Al blister    08-0339-13 Labelling text Labelling text Jul 5, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N50: 50 × 1
(35 mg)
PVC/PVDC/Al blister    08-0339-14 Labelling text Labelling text Jul 5, 2018
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 08-0339
Date of authorisation Nov 27, 2008
Marketing authorisation holder, country Teva Pharma B.V., Netherlands